Echocardiographic and biomarker evidence of plasma volume expansion after short-term steroids administered orally in cats
- PMID: 31816124
- PMCID: PMC6979090
- DOI: 10.1111/jvim.15678
Echocardiographic and biomarker evidence of plasma volume expansion after short-term steroids administered orally in cats
Abstract
Background: Steroids administered PO and intramuscularly are associated with development of congestive heart failure in cats without prior signs of heart disease, but criteria to identify cats at increased risk for steroid-induced heart failure are not established.
Hypothesis: Cats administered steroids PO for 5 to 7 days will develop increased N terminal pro-B-type natriuretic peptide (NT-proBNP) concentration and heart size.
Animals: Ten client-owned cats.
Methods: Observational cohort study. Cats intended to initiate at least a 5-day course of steroids administered PO were consecutively recruited.
Results: Steroids administered PO to cats are not associated with differences in absolute concentration of NT-proBNP (baseline: 49 pmol/L [range, 24-1013]; after steroids: 85 pmol/L [range, 46-1367]; P = .23), blood pressure (baseline: 145 mm Hg [range, 116-163]; after steroids: 145 mm Hg [range, 115-230]; P = .94), nor blood glucose concentration (baseline: 125 mg/dL [range, 92-254]; after steroids: 144 mg/dL [range, 114-307]; P = .43), but are associated with increased median left atrial dimension (baseline: 1.26 cm [range, 0.96-2.03; after steroids: 1.38 [range, 1.03-2.20]; P = .02) and mean left ventricular internal diameter (baseline: 1.55 cm [standard deviation-SD, 0.28; after steroids: 1.72 cm [SD, 0.28]; P = .03). Six of 10 (60%) cats had a percentile change in NT-proBNP >60% after steroids, and 3 of 8 (38%) cats with baseline BNP <100 pmol/L had an NT-proBNP >100 pmol/L after steroids.
Conclusions and clinical importance: Increased heart size and percentage change in individual NT-proBNP concentration suggests plasma volume expansion secondary to steroids administered PO in cats. A serial assessment of an individual cat's change in NT-proBNP might be clinically useful for judging risk for volume expansion.
Keywords: N-terminal pro-B-type natriuretic peptide; budesonide; heart failure; prednisolone.
© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
Conflict of interest statement
Mark A. Oyama has received research funding from IDEXX Laboratories, Westbrook, ME within the past 3 years.
Figures
References
-
- Ployngam T, Tobias AH, Smith SA, Torres SMF, Ross SJ. Hemodynamic effects of methylprednisolone acetate administration in cats. Am J Vet Res. 2006;67(4):583‐587. - PubMed
-
- Pearson AC, Schiff M, Mrosek D, Labovitz AJ, Williams GA. Left ventricular diastolic function in weight lifters. Am J Cardiol. 1986;58:1254‐1259. - PubMed
-
- Muiesan ML, Lupia M, Salvetti M, et al. Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol. 2003;41:2275‐2279. - PubMed
-
- Takano H, Kokubu A, Sugimoto K, Sunahara H, Aoki T, Fujii Y. Left ventricular structural and functional abnormalities in dogs with hyperadrenocorticism. J Vet Cardiol. 2015;17:173‐181. - PubMed
-
- Kornel L. The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance. J Steroid Biochem Mol Biol. 1993;45:195‐203. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous